Patients with a clinical diagnosis of comorbid conditions (e.g., depression, hypertension); people with cognitive impairments; drug or alcohol dependence; people who intentionally overdose for suicidal attempts, and pregnant women will be excluded because each of these population groups has conditions that affect the nature of insulin adherence behavior. This evidence concerns the gene INS and depressive disorder.